SSGSX
Price
$53.43
Change
+$0.01 (+0.02%)
Updated
Jul 27 closing price
Net Assets
4.51B
UBVTX
Price
$85.69
Change
+$0.33 (+0.39%)
Updated
Jul 27 closing price
Net Assets
9.14B
Interact to see
Advertisement

SSGSX vs UBVTX

SSGSX vs UBVTX Comparison Chart in %
View a ticker or compare two or three
VS
SSGSX vs. UBVTX commentary
Jul 28, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SSGSX is a Hold and UBVTX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
UBVTX has more cash in the bank: 9.14B vs. SSGSX (4.51B). UBVTX pays higher dividends than SSGSX: UBVTX (1.35) vs SSGSX (0.51). SSGSX was incepted earlier than UBVTX: SSGSX (27 years) vs UBVTX (9 years). UBVTX (1.35) is less costly to investors than SSGSX (1.23). SSGSX is a more actively managed with annual turnover of: 50.00 vs. UBVTX (35.00). UBVTX has a lower initial minimum investment than SSGSX: UBVTX (0) vs SSGSX (2500). SSGSX annual gain was more profitable for investors over the last year : 18.49 vs. UBVTX (6.72). UBVTX return over 5 years is better than : 17.21 vs. SSGSX (-0.39).
SSGSXUBVTXSSGSX / UBVTX
Total Expense Ratio1.231.3095%
Annual Report Gross Expense Ratio1.231.3591%
Fund Existence27 years9 years-
Gain YTD19.53515.040130%
Front Load6%N/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets4.51B9.14B49%
Annual Yield % from dividends0.511.3538%
Returns for 1 year18.496.72275%
Returns for 3 years10.0612.9178%
Returns for 5 years-0.3917.21-2%
Returns for 10 years41.47N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KAPA0.310.02
+8.70%
Kairos Pharma Ltd.
ENRD5.140.10
+1.98%
EINRIDE AB ADS
TENB32.440.19
+0.59%
Tenable Holdings
VRSN274.82-5.18
-1.85%
VeriSign
AMPG5.06-0.35
-6.38%
Amplitech Group